Adherence to oral antidiabetic therapy in a managed care organization: a comparison of monotherapy, combination therapy, and fixed-dose combination therapy.

@article{Melikian2002AdherenceTO,
  title={Adherence to oral antidiabetic therapy in a managed care organization: a comparison of monotherapy, combination therapy, and fixed-dose combination therapy.},
  author={Caron Melikian and Thomasw. White and Ann M. Vanderplas and Christopher M. Dezii and Eunice Y. Chang},
  journal={Clinical therapeutics},
  year={2002},
  volume={24 3},
  pages={
          460-7
        }
}
BACKGROUND Although medication adherence is one of the most important aspects of the management of diabetes mellitus, low rates of adherence have been documented. OBJECTIVE This study sought to examine medication adherence among patients with diabetes mellitus in a managed care organization who were receiving antidiabetic monotherapy (metformin or glyburide), combination therapy (metformin and glyburide), or fixed-dose combination therapy (glyburide/metformin). METHODS Medication adherence… CONTINUE READING
BETA

Figures and Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 110 CITATIONS

Fixed-dose combination of sitagliptin and metformin for the treatment of type 2 diabetes

  • Diabetes, metabolic syndrome and obesity : targets and therapy
  • 2009
VIEW 3 EXCERPTS
CITES RESULTS
HIGHLY INFLUENCED

A PK/PD study comparing twice-daily to once-daily dosing regimens of ertugliflozin in healthy subjects

  • International journal of clinical pharmacology and therapeutics
  • 2019
VIEW 1 EXCERPT
CITES RESULTS

FILTER CITATIONS BY YEAR

1969
2019

CITATION STATISTICS

  • 4 Highly Influenced Citations

  • Averaged 5 Citations per year over the last 3 years

Similar Papers

Loading similar papers…